These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15798848)

  • 1. Routine provision of nevirapine to women of unknown serostatus: at best a temporary solution to prevent MTCT.
    Newell ML
    Bull World Health Organ; 2005 Mar; 83(3):228-9. PubMed ID: 15798848
    [No Abstract]   [Full Text] [Related]  

  • 2. Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?
    Sint TT; Dabis F; Kamenga C; Shaffer N; de Zoysa IF
    Bull World Health Organ; 2005 Mar; 83(3):224-8. PubMed ID: 15798847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus.
    Stringer JS; Rouse DJ; Sinkala M; Marseille EA; Vermund SH; Stringer EM; Goldenberg RL
    Lancet; 2003 Nov; 362(9398):1850-3. PubMed ID: 14654326
    [No Abstract]   [Full Text] [Related]  

  • 4. The controversies of nevirapine for preventing mother-to-child HIV transmission.
    Smith DM
    AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423
    [No Abstract]   [Full Text] [Related]  

  • 5. This is no time to stop use of nevarapine to prevent mother-to-child transmission of HIV.
    Oleske JM
    AIDS; 2006 Apr; 20(7):1059-60. PubMed ID: 16603859
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks.
    Mellors JW; Chow JY
    Clin Infect Dis; 2009 Feb; 48(4):473-5. PubMed ID: 19133800
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid HIV testing and counselling in labour in a northern Nigerian setting.
    Sagay AS; Musa J; Adewole AS; Imade GE; Ekwempu CC; Kapiga S; Sankale JL; Idoko J; Kanki P
    Afr J Reprod Health; 2006 Apr; 10(1):76-80. PubMed ID: 16999197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scaling the frontier--should traditional birth attendants also be used to provide nevirapine for PMTCT in Uganda?
    Kironde S; Lukwago J; Ssenyonga R
    Afr Health Sci; 2003 Aug; 3(2):102-3. PubMed ID: 12913802
    [No Abstract]   [Full Text] [Related]  

  • 9. Two drugs reduce transmission.
    AIDS Patient Care STDS; 2002 Sep; 16(9):462. PubMed ID: 12412582
    [No Abstract]   [Full Text] [Related]  

  • 10. WHO and UNAIDS continue to support use of nevirapine for prevention of mother-to-child HIV transmission.
    J Adv Nurs; 2002 Sep; 39(6):519. PubMed ID: 12365406
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.
    Westreich D; Eron J; Behets F; Horst Cv; Van Rie A
    J Infect Dis; 2007 Mar; 195(6):837-46. PubMed ID: 17299714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV drug remains unproven without placebo trial.
    Turner VF
    Nature; 2005 Mar; 434(7030):137. PubMed ID: 15758970
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of materno-fetal transmission of HIV by improved delivery techniques combined with nevirapine treatment in women attending two family planning clinics in Yaounde, Cameroon.
    Mbu RE; Mbopi-Keou FX; Alemnji G; Nkengasong JN; Meli C; Eteki N; Nana PN; Ako SN; Tonye RN; Leke RJ
    Int J STD AIDS; 2004 Dec; 15(12):848-9. PubMed ID: 15601503
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV: mother to child transmission.
    Volmink J; Mahlat U
    Clin Evid; 2005 Jun; (13):823-33. PubMed ID: 16135280
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
    Nightingale S; Dabis F
    J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674
    [No Abstract]   [Full Text] [Related]  

  • 16. Reports on nevirapine threaten public health.
    Lane HC; Folkers GK; Fauci AS
    Nat Med; 2005 Mar; 11(3):245. PubMed ID: 15746930
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of drug-resistant HIV-1 in latent reservoirs.
    Dahl V; Palmer S
    J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of children born of AIDS mothers in Tsevie hospital regional center, Togo].
    Djadou KE; Ocloo A; Dokounor D; Agbodjan-Djossou O; Akakpossa A; Atakouma DY
    Bull Soc Pathol Exot; 2007 Oct; 100(4):287-8. PubMed ID: 17982861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
    Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
    Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.